window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 21, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Precision Medicine

  • Digital & Data,Drug Discovery & Development,Research & Development,Therapeutic Areas

    Nucs AI taps Segmed’s 150 million imaging studies to strengthen oncology AI

    Nucs AI has partnered with healthcare data specialist Segmed to [...]

    July 15, 2026
  • Drug Discovery & Development,Genomics and sequencing,Research & Development

    Nucleome strengthens 3D genomics platform with US patent for Micro Capture-C technology

    Nucleome Therapeutics has strengthened its intellectual property portfolio after the [...]

    July 14, 2026
  • Clinical & Regulatory,Medical devices,Research & Development,Therapeutic Areas

    Alamar launches blood-based eMTBR-Tau assay for Alzheimer’s disease research

    Alamar Biosciences has launched what it describes as the first [...]

    July 8, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Meteor Biotech joins South Korea consortium to advance brain organoid commercialisation platform

    Meteor Biotech has joined a South Korean government-backed consortium aimed [...]

    June 23, 2026
  • Medical devices

    Singapore researchers develop nanosensor for rapid gut biomarker detection

    Researchers in Singapore have developed a fluorescent nanosensor capable of [...]

    June 19, 2026
  • Digital & Data,Genomics and sequencing

    Wellcome Genome Campus expands AI and genomics ambitions with new advisory group

    The Wellcome Genome Campus has established a Science and Technology [...]

    June 18, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Medicus files IND for genomics-enabled Phase 2 endometriosis trial

    Medicus Pharma has submitted an investigational new drug application in [...]

    June 11, 2026
  • Biotech & Pharma Business,Digital & Data

    IMU Biosciences extends Series A to $53M to advance immune profiling platform

    IMU Biosciences has extended its Series A financing to more [...]

    June 6, 2026
  • Central Nervous System,Digital & Data,Drug Delivery & Formulation,Drug Discovery & Development,Therapeutic Areas

    Bonito Biosciences partners with DaltonTx on AI-driven RNA delivery research

    Bonito Biosciences has entered a collaboration with DaltonTx to develop [...]

    June 6, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Japan pushes AI clinical trials agenda as global pharma leaders gather in Tokyo

    Japan’s push to modernise clinical research through artificial intelligence and [...]

    May 7, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Adneuris licenses Phase 3 pain therapy cebranopadol to Conba for Greater China
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics
  • Latent Labs opens lab-validated AI drug design platform to researchers worldwide
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
  • PET imaging reveals widespread synaptic loss in schizophrenia
    Categories: Clinical & Regulatory, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top